Luye Pharma Group LTD.
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, which derives maximum revenue; Cardiovascular system drugs; Alimentary tract and metabolism drugs; Central nervous system drugs; and others. Geographically, the group derives maximum revenue from Chinese Mainland, while it also has its presence in Asia (other than the Chinese mainland), European Union, and Other countries.
公司地址 Hongqiao Road 1438, 22nd Floor, Gubei International Fortune Center II, Changning District, Shanghai, CHN
電話號碼 +86 2153894101
傳真號碼 +86 2162376269
公司網頁 https://www.luye.cn
員工數量 5221
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Dian Bo Liu Chairman of the Board and Chief Executive Officer -- 29/04/2025
Mr. Rong Bing Yang Vice Chairman of the Board -- 29/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Liming Huang Director 29/04/2025
Professor Yuk Lam Lo Independent Director 29/04/2025
Mr. Sze Chung Jojo Choy Independent Director 29/04/2025
Mr. Man Kit Leung Independent Director 29/04/2025
Ms. Lian Xia Independent Director 29/04/2025
Dr. Dong Lyu Director 29/04/2025
Mr. Dian Bo Liu Chairman of the Board and Chief Executive Officer 29/04/2025
Mr. Rong Bing Yang Vice Chairman of the Board 29/04/2025
Mr. Hui Xian Yuan Director 29/04/2025
Ms. Yuan Yuan Zhu Director 29/04/2025
Mr. Rui Lin Song Director 29/04/2025
Mr. Hua Qiao Zhang Independent Director 29/04/2025
 
所屬ETF (更新日期: 23/05/2026 04:27)
代號 名稱 佔比% ▼ 持有日期
IEMGiShares Core MSCI Emerging Markets ETF0.62%30/04/2026
AVEMAvantis Emerging Markets Equity ETF0.39%30/04/2026
VEUVanguard FTSE All-Wld ex-US ETF0.12%30/04/2026
DFEMDimensional Emerging Markets Cr Eq 2 ETF0.09%30/04/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.08%30/04/2026
SCHESchwab Emerging Markets Equity ETF™0.06%30/04/2026
DFAXDimensional World ex US Core Eq 2 ETF0.05%30/04/2026
VTVanguard Total World Stock ETF0.05%30/04/2026
DFAEDimensional Emerging Core Equity Mkt ETF0.05%30/04/2026
DFEVDimensional Emerging Markets Value ETF0.04%30/04/2026
SPEMState Street® SPDR® Portfolio EM ETF0.04%30/04/2026
EWXState Street® SPDR® S&P® EM Sm Cp ETF0.04%30/04/2026
ECNSiShares MSCI China Small-Cap ETF0.03%30/04/2026
EEMSiShares MSCI Emerging Markets Sm-Cp ETF0.02%30/04/2026
AGNGGlobal X Aging Population ETF0.02%30/04/2026
VSGXVanguard ESG International Stock ETF0.01%30/04/2026
GXCState Street® SPDR® S&P® China ETF0.01%30/04/2026
DFSEDimensional Emerging Mrkts Sstby Cr 1ETF0.01%30/04/2026
AVEEAvantis Emerging Markets Sm Cp Eq ETF0.01%30/04/2026
FLCHFranklin FTSE China ETF0.005%30/04/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.